Productus
-
Semaglutide ad Type II diabete
Nomen: semaglutide
Cas Number: 910463-68-2
Molecular Formula: c187h291n45o59
M. pondus: 4113,57754
Einecs Number: 203-405-2
-
1- (IV-methoxyphen) methanamine
Potest adhiberi ad synthesis de pharmaceutical intermedia. Paulo nocet aqua. Ne merito vel magna quantitates venient in contactum cum groundwater, waterways aut purgamentorum systems. Sine imperio permission, non seminis materiae in ambiente environment ad vitare oxides, acida. , Aeris, carbo carbonis dioxide contactus, ut continens signatus, posuit in stricta extractor, et copia in a frigus, siccum est.
-
2,6-Dihydroxy-III-Cyano-IV-methyl pyridine
CAS non.: 5444-02-0
MOLECULA: C7H6N2O2
M. pondus: 150.13
Einecs: 226-639-7
Melting Point: CCCXV ° C (Dec.) (Gen.)
Fervens Point: 339.0 ± 42.0 ° C (praedicta)
Density: 1.38 ± 0.1 G / CM3 (praedicta)
Acidited coefficiens: (Pka) 3.59 ± 0.58 (praedicta)
-
Conventional amino acidum seriem
No.
Productus
Cas No.
Applicatio
1
Fmoc, Arg (PBF) -OH 154445-77-9 Maxime peptides
2
FMOC, ASN (TT) -OH 13388-59-1 Maxime peptides
3
Fmoc-ASP (otbu) -ohh 71989-14-5 Maxime peptides
-
D-amino acida series solidum tempus synthesis
No
Productus
Cas No.
1
FMOC-3 (II-Naphthyl) -D-Ala 138774-94-4 2
AC-3- (II-Naphthyl) -D-Ala-O 37440-01-0 3
FMOC-3 (III-Pyridinyl) -D-ALA-O 142994-45-4 -
GLP-I protected amino acidum latus catenam modificationem
Non.
Productus
Cas No.
1
Fmoc, Lys (MTT) -OH 167393-62-6 2
Fmoc, lys (Alloc) -oh 146982-27-6 3
Fmoc, lys (ivdde) -ohh 150629-67-7 4
Fmoc, lys (MMT) -ohh 159857-60-0 -
Gnrh Anagonist propter Peptides synthesis
NO
Productus
Cas No.
Applicatio
1
AC-3- (II-Naphthyl) -D-Ala-O
37440-01-0
Maxime products
2
FMOC-3 (III-Pyridinyl) -D-ALA-O
142994-45-4
Maxime products
3
Fmoc-IV-chloro-d-phe-oh
142994-19-2
Maxime products
-
Impura of Amino Acidum propter synthesize dapibus
NO
Productus
Cas non
1
Fmoc-D-Ala-D-Ala
NA
2
Fmoc-β-Ala-D-Ala
NA
3
Fmoc, Arg (PBF) -arg (PBF) -oh
NA
-
Alii protected amino acida ad disulfide vinculum
NO
Productus
Cas non
Applicatio
1
Fmoc-CYS (MMT) -OH
177582-21-7
Disulfide vinculum
2
Fmoc-cys (IV-allylbutyrate) -oh
/
Disulfide vinculum
3
MPA (TT) -OH
27144-18-9
Finis sequentia
-
Tadalafil 171596-29-5 tractare erectile Dysfunction in homines
CAS non: 171596-29-5
Molecular Formula: C22H19N3O4
M. pondus: 389,4
Einecs Number: 687-782-2
Melting Point: 298-300 ° C
Effusus Point: 679.1 ± 55.0 ° C (praedicta)
Color Alba ad Beige
Optical Activity: (opticaCelltivity) [α] / D + 68TO + LXXVIII °, C = I in Chloro Form: D
Stabilitas: instabiles in Methanol
-
Pregabalin ad curatio periphericis neuralgia et adjuvant curatio de localized partialium invasiones
Melting Point: 194-196 ° C
Rotation specifica: D23 + 10.52 ° (c = 1.06inwater)
Ferventis Point: 274.0 ± 23.0 ° C (praedicta)
Density: 0.997 ± 0.06G / CM3 (praedicta)
Flash Point: IX ° F
Repono conditionibus: 2-8 °
Solubility: Deionized aqua: ≥10mg / ml
Forma: Whitepowder
Acidited coefficiens: (Pka) 4.23 ± 0.10 (praedicta)
Aqua Solubility: Solublet100MMinwater
-
Sildenafil citrate agitur erectile dysfunction 171599-83-0
Chemical Formula: C28H38N6O11S
Molecular pondus: 666,70
Cas Number: 171599-83-0
Einecs Number: 200-659-6
Melting Point: 187-189 ℃
Effusus Point: 672,4 ℃
Flash Point: 360.5 ℃
Density: 1.445g / CM3
Index refractive: 1.683